Thomas White International’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,510
Closed -$460K 286
2022
Q3
$460K Hold
10,510
0.11% 181
2022
Q2
$551K Hold
10,510
0.11% 171
2022
Q1
$544K Hold
10,510
0.09% 184
2021
Q4
$621K Hold
10,510
0.1% 179
2021
Q3
$452K Hold
10,510
0.07% 206
2021
Q2
$412K Hold
10,510
0.06% 214
2021
Q1
$381K Hold
10,510
0.06% 217
2020
Q4
$387K Sell
10,510
-568
-5% -$20.8K 0.06% 211
2020
Q3
$386K Hold
11,078
0.07% 205
2020
Q2
$344K Hold
11,078
0.07% 212
2020
Q1
$343K Buy
+11,078
New +$377K 0.08% 193

Other funds holding PFE

Thomas White International's PFE Position: Q4 2022 in Review

Thomas White International sold out of Pfizer (PFE) in Q4 2022, closing a stake of 10,510 shares — an estimated $460K sold.

Thomas White International first reported a position in PFE in Q1 2020 and held it in 11 quarters. The position peaked at $621K in Q4 2021. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • Thomas White International reported no remaining Pfizer position as of Q4 2022 after selling out during the quarter.
  • Thomas White International sold 10,510 Pfizer shares in Q4 2022, an estimated $460K.
  • Thomas White International first reported a position in Pfizer in Q1 2020 and held it in 11 quarters.
  • Thomas White International's Pfizer position peaked at $621K in Q4 2021.
  • 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Thomas White International's 13F filing for Q4 2022, filed 15 Feb 2023.